Advantage Trust »

Merck & Co shares owned by Advantage Trust

Quarter-by-quarter ownership of Merck & Co (MRK) shares owned by Advantage Trust from 13F filings

Historical chart of Advantage Trust investment in Merck & Co

Tip: Access up to 7 years of quarterly data

All positions including Merck & Co held by Advantage Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merck & Co by Advantage Trust

Quarter filed Position value Share count Share price at filing
2024-03-31 $46k 350 131.95
2023-12-31 $76k 700 109.02

More positions owned by Advantage Trust

JP Morgan Active Growth ETF Active Growth (JGRO)
Vanguard Mid-Cap ETF Mid Cap Etf (VO)
Vanguard Growth ETF Growth Etf (VUG)
First Trust SMID Cap Rising Dividend Achievers ETF Smid Risng Etf (SDVY)
Vanguard Value ETF Value Etf (VTV)
Vanguard Information Technology ETF Inf Tech Etf (VGT)
Fidelity Enhanced International ETF Enhanced Intl (FENI)
JP Morgan ActiveBuilders Emerging Markets Equity ETF Activebldrs Emer (JEMA)
Vanguard Real Estate ETF Real Estate Etf (VNQ)
IShares MSCI USA Momentum Factor ETF Msci Usa Mmentm (MTUM)
First Trust NASDAQ Cybersecurity ETF Nasdaq Cyb Etf (CIBR)
SPDR S&P Kensho New Economies Composite ETF S&p Kensho New (KOMP)
Vanguard Sector Index Health Care ETF Health Car Etf (VHT)
Defiance 5G Next Generation Connectivity ETF Defiance Next (FIVG)
IShares Biotechnology ETF Ishares Biotech (IBB)

View all positions for Advantage Trust

Top funds holding Merck & Co

Vanguard Group
BlackRock
Wellington Management Company
Geode Capital Management
FMR
Morgan Stanley
Bank of America Corporation
T. Rowe Price Associates
Northern Trust
Jpmorgan Chase & Co
Legal & General Group
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Franklin Resources
Charles Schwab Investment Management

View all funds holding Merck & Co